Search Within

Malin Lisa Hultcrantz

Formats
  1. Meeting Abstract (178)
  2. Journal Article (73)
  3. Research Letter (10)
  4. Guidelines (6)
  5. Correspondence (3)
  6. Review (3)
  7. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (274)
  2. Department of Medicine (274)
  3. Hematologic Malignancies, Division of (274)
  4. Myeloma (274)
  5. Sloan Kettering Institute Postdocs (274)
  6. Hematologic Malignancies Research (189)

More Groups

People
  1. Sham Mailankody (158)
  2. Neha Korde (155)
  3. Alexander Lesokhin (150)
  4. Hani Hassoun (144)
  5. Urvi Shah (135)
  6. Sergio Giralt (129)

More People

Years
  1. 2025 (15)
  2. 2024 (46)
  3. 2023 (51)
  4. 2022 (52)
  5. 2021 (30)
  6. 2020 (26)

More Years

Publications
  1. Blood (104)
  2. Clinical Lymphoma, Myeloma and Leukemia (50)
  3. Journal of Clinical Oncology (17)
  4. Blood Cancer Journal (14)
  5. Haematologica (10)
  6. Blood Advances (8)

More Publications

Publishers
  1. American Society of Hematology (112)
  2. Elsevier Inc. (56)
  3. Nature Publishing Group (22)
  4. American Society of Clinical Oncology (17)
  5. Ferrata Storti Foundation (10)
  6. John Wiley & Sons (7)

More Publishers

Results (274)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma
    Journal Article

    Landgren, O.; Hofmann, J. N.; McShane, C. M.; Santo, L.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Kazandjian, D.; Murata, K.; Thoren, K.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
    Journal Article

    Rustad, E. H.; Hultcrantz, M.; Yellapantula, V. D.; Akhlaghi, T.; Ho, C.; Arcila, M. E.; Roshal, M.; Patel, A.; Chen, D.; Devlin, S. M.; more...
    PLoS ONE (2019)

    Fulltext@MSK | Save
  • Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
    Journal Article

    Kazandjian, D.; Hill, E.; Hultcrantz, M.; Rustad, E. H.; Yellapantula, V.; Akhlaghi, T.; Korde, N.; Mailankody, S.; Dew, A.; Papaemmanuil, E.; more...
    Blood Cancer Journal (2019)

    Fulltext@MSK | Save
  • Molecular underpinnings of clinical disparity patterns in African American (AA) versus Caucasian American (CA) multiple myeloma (MM) patients
    Meeting Abstract

    Hill, E. M.; Kwok, M.; Yellapantula, V.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Papaemmanuil, E.; Maric, I.; Kazandjian, D. G.; Landgren, O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save